Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“Toripalimab plus axitinib in patients with stage 4 mucosal melanoma: 3-year survival update and biomarker analysis
- 9pts phase data
- Median PFS 7.5m
- 3 year OS 3%
- gene GEP correlates with increased PFS and OS.”
Authors: Siming Li, Xiaowen Wu, Xieqiao Yan, Li Zhou, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Lili Mao, Bin Lian, Xuan Wang, Xue Bai, Jie Dai, Yan Kong, Xiongwen Tang, Hui Feng, Sheng Yao, Keith T Flaherty, Jun Guo, Xinan Sheng
